{"entity":{"type":"insider","cik":"0001308105","url":"/insider/0001308105","json_url":"/insider/0001308105.json","name":"SKIBSTED RUSSELL","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2011-05-19","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"SKIBSTED RUSSELL","source":"filing","n_filings":10,"first_seen":"2011-05-19","last_seen":"2026-07-01"}],"transactions":[{"id":6051666,"accession":"0000897069-26-001478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001478","line_url":"/filing/0000897069-26-001478#line-1","is_derivative":false,"issuer_cik":"0001308105","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001308105","owner_cik":"0001308105","owner_name":"SKIBSTED RUSSELL","owner_display_name":"SKIBSTED RUSSELL","owner_url":"/insider/0001308105","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3277.0,"shares_display":"3,277","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":6324.61,"total_display":"6,324.61","total_whole":"6,325","shares_owned_after":16689.0,"shares_owned_after_display":"16,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-01","scope":"insider"},{"id":6051663,"accession":"0000897069-26-001412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001412","line_url":"/filing/0000897069-26-001412#line-1","is_derivative":false,"issuer_cik":"0001308105","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001308105","owner_cik":"0001308105","owner_name":"SKIBSTED RUSSELL","owner_display_name":"SKIBSTED RUSSELL","owner_url":"/insider/0001308105","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2654.0,"shares_display":"2,654","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":5891.88,"total_display":"5,891.88","total_whole":"5,892","shares_owned_after":13412.0,"shares_owned_after_display":"13,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-16","scope":"insider"},{"id":5768176,"accession":"0000897069-26-001293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001293","line_url":"/filing/0000897069-26-001293#line-1","is_derivative":false,"issuer_cik":"0001308105","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001308105","owner_cik":"0001308105","owner_name":"SKIBSTED RUSSELL","owner_display_name":"SKIBSTED RUSSELL","owner_url":"/insider/0001308105","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2292.0,"shares_display":"2,292","price_per_share":2.57,"price_display":"2.57","price_state":"stated","total_value":5890.44,"total_display":"5,890.44","total_whole":"5,890","shares_owned_after":10758.0,"shares_owned_after_display":"10,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-29","filed_date":"2026-06-01","scope":"insider"},{"id":5743088,"accession":"0000897069-26-001171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001171","line_url":"/filing/0000897069-26-001171#line-1","is_derivative":false,"issuer_cik":"0001308105","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001308105","owner_cik":"0001308105","owner_name":"SKIBSTED RUSSELL","owner_display_name":"SKIBSTED RUSSELL","owner_url":"/insider/0001308105","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1984.0,"shares_display":"1,984","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":5892.48,"total_display":"5,892.48","total_whole":"5,892","shares_owned_after":8466.0,"shares_owned_after_display":"8,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-19","scope":"insider"},{"id":5738451,"accession":"0000897069-26-001008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001008","line_url":"/filing/0000897069-26-001008#line-1","is_derivative":false,"issuer_cik":"0001308105","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001308105","owner_cik":"0001308105","owner_name":"SKIBSTED RUSSELL","owner_display_name":"SKIBSTED RUSSELL","owner_url":"/insider/0001308105","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2190.0,"shares_display":"2,190","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":5891.1,"total_display":"5,891.10","total_whole":"5,891","shares_owned_after":6498.0,"shares_owned_after_display":"6,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-05-01","scope":"insider"},{"id":5743083,"accession":"0000897069-26-000902","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000902","line_url":"/filing/0000897069-26-000902#line-1","is_derivative":false,"issuer_cik":"0001308105","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001308105","owner_cik":"0001308105","owner_name":"SKIBSTED RUSSELL","owner_display_name":"SKIBSTED RUSSELL","owner_url":"/insider/0001308105","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1984.0,"shares_display":"1,984","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":5892.48,"total_display":"5,892.48","total_whole":"5,892","shares_owned_after":4308.0,"shares_owned_after_display":"4,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-17","scope":"insider"},{"id":5914757,"accession":"0000897069-26-000754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000754","line_url":"/filing/0000897069-26-000754#line-1","is_derivative":false,"issuer_cik":"0001308105","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001308105","owner_cik":"0001308105","owner_name":"SKIBSTED RUSSELL","owner_display_name":"SKIBSTED RUSSELL","owner_url":"/insider/0001308105","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2324.0,"shares_display":"2,324","price_per_share":2.535,"price_display":"2.54","price_state":"stated","total_value":5891.34,"total_display":"5,891.34","total_whole":"5,891","shares_owned_after":2324.0,"shares_owned_after_display":"2,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-01","scope":"insider"},{"id":5254390,"accession":"0001209191-17-050305","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-050305","line_url":"/filing/0001209191-17-050305#line-1","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"BIOTIME INC","issuer_ticker":"BTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001308105","owner_name":"SKIBSTED RUSSELL","owner_display_name":"SKIBSTED RUSSELL","owner_url":"/insider/0001308105","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Shares, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.6424,"price_display":"2.64","price_state":"stated","total_value":5284.8,"total_display":"5,284.80","total_whole":"5,285","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-23","filed_date":"2017-08-25","scope":"insider"},{"id":2888970,"accession":"0001102624-12-000460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001102624-12-000460","line_url":"/filing/0001102624-12-000460#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001308105","owner_name":"SKIBSTED RUSSELL","owner_display_name":"SKIBSTED RUSSELL","owner_url":"/insider/0001308105","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7027.0,"shares_display":"7,027","price_per_share":0.2388,"price_display":"0.24","price_state":"stated","total_value":1678.0476,"total_display":"1,678.05","total_whole":"1,678","shares_owned_after":17027.0,"shares_owned_after_display":"17,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-23","filed_date":"2012-05-23","scope":"insider"},{"id":9140055,"accession":"0001144204-11-031187","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-11-031187","line_url":"/filing/0001144204-11-031187","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001308105","owner_name":"SKIBSTED RUSSELL","owner_display_name":"SKIBSTED RUSSELL","owner_url":"/insider/0001308105","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.4225,"price_display":"0.42","price_state":"stated","total_value":8450.0,"total_display":"8,450.00","total_whole":"8,450","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-18","filed_date":"2011-05-19","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001533743","name":"Processa Pharmaceuticals, Inc.","url":"/issuer/0001533743","role":"Officer (Chief Financial Officer)","n_filings":7,"first_seen":"2026-04-01","last_seen":"2026-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000876343","name":"BIOTIME INC","url":"/issuer/0000876343","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2017-08-25","last_seen":"2017-08-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001261734","name":"AEOLUS PHARMACEUTICALS, INC.","url":"/issuer/0001261734","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2011-05-19","last_seen":"2012-05-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001308105","retrieved_at":"2026-08-23T04:26:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}